Meningiomas and schwannomas are common tumors of the nervous system. Limited data are available on the role of the chemokine/receptor axis in meningiomas and schwannomas. In our study, for the first time, the mRNA and protein expression levels of three chemokine/receptor pairs (CX3CL1/CX3CR1, CXCL12/CXCR4 and CXCL16/CXCR6) were investigated in human meningiomas and schwannomas by real-time RT-PCR and immunohistochemistry. Our results showed that chemokines and their receptors are involved in the pathogenisis of human meningiomas and schwannomas
Although most meningiomas are encapsulated and benign tumors with limited numbers of genetic aberrat...
OBJECT: The goal of this study was to investigate whether the janus kinase/signal transducer and act...
The authors assessed 116 cases of meningiomas classified as typical, atypical and anaplastic and the...
Recent evidence indicates that cancer cells express chemokine (CK) receptors and that their signalin...
BACKGROUND: Meningiomas are the most common benign CNS neoplasms with higher prevalence in women. ...
CXCR4 and CXCR7 chemokine receptors, and their ligands CXCL11 and CXCL12, have been often involved i...
Background: Meningiomas account for about a third of all central nervous system tumours worldwide. T...
BACKGROUND: Meningiomas constitute about 13-26% of primary intracranial tumours. Although most of t...
Meningiomas, being mostly benign tumors, are derived from the arachnoid cap cells, their etiopathoge...
Various aspects, including diagnosis, therapy, and prognosis, of two brain tumors (meningioma and sc...
Background: Meningiomas are slow growing intracranial and intraspinal neoplasms with a tendency to r...
Research over the last decade recognized the importance of novel molecular pathways in pathogenesis ...
Meningioma is a tumor that arises from the meningothelial cells of the arachnoid membranes which are...
Meningioma is cancer of the meninges, the protective lining of the brain and spinal cord. Currently ...
Chemokines participate in cellular processes associated with tumor proliferation, migration, and ang...
Although most meningiomas are encapsulated and benign tumors with limited numbers of genetic aberrat...
OBJECT: The goal of this study was to investigate whether the janus kinase/signal transducer and act...
The authors assessed 116 cases of meningiomas classified as typical, atypical and anaplastic and the...
Recent evidence indicates that cancer cells express chemokine (CK) receptors and that their signalin...
BACKGROUND: Meningiomas are the most common benign CNS neoplasms with higher prevalence in women. ...
CXCR4 and CXCR7 chemokine receptors, and their ligands CXCL11 and CXCL12, have been often involved i...
Background: Meningiomas account for about a third of all central nervous system tumours worldwide. T...
BACKGROUND: Meningiomas constitute about 13-26% of primary intracranial tumours. Although most of t...
Meningiomas, being mostly benign tumors, are derived from the arachnoid cap cells, their etiopathoge...
Various aspects, including diagnosis, therapy, and prognosis, of two brain tumors (meningioma and sc...
Background: Meningiomas are slow growing intracranial and intraspinal neoplasms with a tendency to r...
Research over the last decade recognized the importance of novel molecular pathways in pathogenesis ...
Meningioma is a tumor that arises from the meningothelial cells of the arachnoid membranes which are...
Meningioma is cancer of the meninges, the protective lining of the brain and spinal cord. Currently ...
Chemokines participate in cellular processes associated with tumor proliferation, migration, and ang...
Although most meningiomas are encapsulated and benign tumors with limited numbers of genetic aberrat...
OBJECT: The goal of this study was to investigate whether the janus kinase/signal transducer and act...
The authors assessed 116 cases of meningiomas classified as typical, atypical and anaplastic and the...